Brett Jorgensen

1.6k total citations
13 papers, 499 citations indexed

About

Brett Jorgensen is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Brett Jorgensen has authored 13 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Immunology. Recurrent topics in Brett Jorgensen's work include Monoclonal and Polyclonal Antibodies Research (8 papers), CAR-T cell therapy research (6 papers) and Glycosylation and Glycoproteins Research (3 papers). Brett Jorgensen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), CAR-T cell therapy research (6 papers) and Glycosylation and Glycoproteins Research (3 papers). Brett Jorgensen collaborates with scholars based in United States, United Kingdom and Australia. Brett Jorgensen's co-authors include Peter I. Mackenzie, Philip A. Gregory, Rikke Lewinsky, Wen Xie, Dione Gardner-Stephen, Carlos García, Vivian Barry-Hamilton, Amanda Mikels‐Vigdal, Derek Marshall and Ruth Wang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Brett Jorgensen

13 papers receiving 487 citations

Peers

Countries citing papers authored by Brett Jorgensen

Since Specialization

Citations

This map shows the geographic impact of Brett Jorgensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett Jorgensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett Jorgensen more than expected).

Fields of papers citing papers by Brett Jorgensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett Jorgensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett Jorgensen. The network helps show where Brett Jorgensen may publish in the future.

Co-authorship network of co-authors of Brett Jorgensen

This figure shows the co-authorship network connecting the top 25 collaborators of Brett Jorgensen. A scholar is included among the top collaborators of Brett Jorgensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett Jorgensen. Brett Jorgensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHL 2021 ·mAbs ·(unknown), (unknown), (unknown), Andrew Boudreau, Benjamin Buelow, Kevin Dang, Laura Davison, Katherine E. Harris, Brett Jorgensen, Heather Ogana, Duy Pham, Ute Schellenberger, Wim van Schooten, Roland Buelow, Suhasini Iyer, Nathan D. Trinklein, Udaya S. Rangaswamy	22
2	TNB-486, a Novel Fully Human Bispecific CD19 x CD3 Antibody That Kills CD19-Positive Tumor Cells with Minimal Cytokine Secretion 2019 ·Blood ·(unknown), Ben Buelow, Udaya S. Rangaswamy, (unknown), Andrew Boudreau, Kevin Dang, Laura Davison, Shelley Force Aldred, Katherine M. Harris, Suhasini Iyer, Brett Jorgensen, Duy Pham, (unknown), Ute Schellenberger, (unknown), Nathan D. Trinklein, Wim van Schooten	6
3	Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies 2019 ·mAbs ·Nathan D. Trinklein, Duy Pham, Ute Schellenberger, Ben Buelow, Andrew Boudreau, Priya Choudhry, Starlynn Clarke, Kevin Dang, Katherine E. Harris, Suhasini Iyer, Brett Jorgensen, (unknown), Udaya S. Rangaswamy, (unknown), Omid Vafa, Arun P. Wiita, Wim van Schooten, Roland Buelow, Shelley Force Aldred	82
4	A novel CD3xPSMA bispecific antibody for efficient T cell mediated killing of prostate tumor cells with minimal cytokine release. 2019 ·Journal of Clinical Oncology ·Starlynn Clarke, Kevin Dang, Yuping Li, (unknown), Duy Pham, (unknown), Laura Davison, Katherine E. Harris, Brett Jorgensen, Ute Schellenberger, Nathan D. Trinklein, (unknown), Roland Buelow, Wim van Schooten, Shelley Force Aldred, Ben Buelow	2
5	A novel T-cell bispecific antibody platform for efficient T-cell mediated killing of tumor cells with minimal cytokine release. 2018 ·Journal of Clinical Oncology ·Udaya S. Rangaswamy, Andrew Boudreau, Ben Buelow, Starlynn Clarke, Kevin Dang, Laura Davison, Shelley Force Aldred, Katherine E. Harris, Suhasini Iyer, Brett Jorgensen, Heather Ogana, Duy Pham, (unknown), Nathan D. Trinklein, Ute Schellenberger, (unknown), Omid Vafa, Wim van Schooten	4
6	Multispecific antibodies targeting CD38 show potent tumor-specific cytotoxicity. 2018 ·Journal of Clinical Oncology ·Shelley Force Aldred, Andrew Boudreau, Ben Buelow, Starlynn Clarke, Kevin Dang, Laura Davison, Katherine E. Harris, Suhasini Iyer, Brett Jorgensen, Heather Ogana, Duy Pham, (unknown), Udaya S. Rangaswamy, Ute Schellenberger, Nathan D. Trinklein, (unknown), Omid Vafa, Wim van Schooten	2
7	PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia 2016 ·PLoS ONE ·Ivan H. Chan, Dennis Van Hoof, (unknown), (unknown), (unknown), Brett Jorgensen, Scott McCauley, (unknown), Martin Oft, Peter Van Vlasselaer, John B. Mumm	7
8	Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer 2015 ·PLoS ONE ·Derek Marshall, Susan K. Lyman, Scott McCauley, Maria Kovalenko, Rhyannon Spangler, (unknown), Michael Lee, (unknown), Vivian Barry-Hamilton, Haben Ghermazien, Amanda Mikels‐Vigdal, Carlos García, Brett Jorgensen, (unknown), Ruth Wang, Joanne I. Adamkewicz, Victoria Smith	165
9	Rational Optimization of a Bispecific Ligand Trap Targeting EGF Receptor Family Ligands 2009 ·Molecular Medicine ·Jin Pei, Juan Zhang, Malgorzata Beryt, (unknown), Cathleen Brdlik, Ying Feng, Xiaomei Bai, Jim Liu, Brett Jorgensen, H. Michael Shepard	10
10	Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activityin vitroand in human tumor xenografts 2008 ·Molecular Cancer Therapeutics ·Jay Sarup, Jin Pei, (unknown), Xiaomei Bai, Malgorzata Beryt, Cathleen Brdlik, Jeffrey N. Higaki, Brett Jorgensen, Francis W. Lau, Peter F. Lindley, Jim Liu, Irene Ni, (unknown), Rajendra Kumari, Susan A. Watson, Juan Zhang, H. Michael Shepard	28
11	Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis 2008 ·Arthritis Research & Therapy ·Jin Pei, Juan Zhang, Percy F. Sumariwalla, Irene Ni, Brett Jorgensen, (unknown), (unknown), Marc Feldmann, H. Michael Shepard, Ewa Paleolog	33
12	Regulation of UDP Glucuronosyltransferase Genes 2003 ·Current Drug Metabolism ·Peter I. Mackenzie, Philip A. Gregory, Dione Gardner-Stephen, Rikke Lewinsky, Brett Jorgensen, (unknown), Wen Xie, (unknown)	88
13	Humanization and characterization of the anti-HLA-DR antibody 1D10 2001 ·International Journal of Cancer ·(unknown), Brian K. Link, J. Yun Tso, Max Vásquez, Brett Jorgensen, Hong Wang, William C. Hall, George J. Weiner	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact